| Year |
Citation |
Score |
| 2018 |
Suárez-Calvet M, Capell A, Araque Caballero MÁ, Morenas-Rodríguez E, Fellerer K, Franzmeier N, Kleinberger G, Eren E, Deming Y, Piccio L, Karch CM, Cruchaga C, Paumier K, Bateman RJ, Fagan AM, et al. CSF progranulin increases in the course of Alzheimer's disease and is associated with sTREM2, neurodegeneration and cognitive decline. Embo Molecular Medicine. PMID 30482868 DOI: 10.15252/Emmm.201809712 |
0.303 |
|
| 2014 |
Fagan AM, Xiong C, Jasielec MS, Bateman RJ, Goate AM, Benzinger TL, Ghetti B, Martins RN, Masters CL, Mayeux R, Ringman JM, Rossor MN, Salloway S, Schofield PR, Sperling RA, et al. Longitudinal change in CSF biomarkers in autosomal-dominant Alzheimer's disease. Science Translational Medicine. 6: 226ra30. PMID 24598588 DOI: 10.1126/Scitranslmed.3007901 |
0.314 |
|
| 1996 |
Fagan AM, Zhang H, Landis S, Smeyne RJ, Silos-Santiago I, Barbacid M. TrkA, but not TrkC, receptors are essential for survival of sympathetic neurons in vivo. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 16: 6208-18. PMID 8815902 DOI: 10.1523/Jneurosci.16-19-06208.1996 |
0.496 |
|
| 1995 |
Silos-Santiago I, Molliver DC, Ozaki S, Smeyne RJ, Fagan AM, Barbacid M, Snider WD. Non-TrkA-expressing small DRG neurons are lost in TrkA deficient mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 15: 5929-42. PMID 7666178 DOI: 10.1523/Jneurosci.15-09-05929.1995 |
0.475 |
|
| 1994 |
Fagan AM, Barbacid M, Smeyne RJ. The role of nerve growth factor family receptors in the development of the mammalian nervous system European Neuropsychopharmacology. 4: 226. DOI: 10.1016/0924-977X(94)90054-X |
0.462 |
|
| Show low-probability matches. |